Press Releases

Data Published in Sensors Supports the Use of Global Kinetics’ Personal KinetiGraph® for Objective Assessment of Parkinson’s Disease Patients Who May Benefit From Device-Assisted Therapies

Novel screening tool provides first objective assessment for managing referral for device-assisted therapy (DAT), including deep brain stimulation (DBS) and infusion therapies, and has potential to improve management of Parkinson’s Disease

Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use of data from its wearable FDA-cleared watch, the Personal KinetiGraph® (PKG®), can provide an objective approach to identifying Parkinson’s Disease (PD) patients who may be candidates for device-assisted therapies (DAT) such as deep brain stimulation (DBS).

Read full press release here

Global Kinetics Corporation’s PKG® Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication Optimization, and PatientClinician Conversations in Parkinson’s Disease

Data Recently Presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical Study Continues Enrollment at 10 Movement Disorder Clinics in the U.S.

Global Kinetics today reported data that was recently presented at poster presentation sessions during the 2019 American Academy of Neurology’s (AAN) Annual Meeting in Philadelphia, PA, May 4 – 10, 2019 and the 2019 Parkinson Study Group (PSG) in Phoenix, AZ, April 5 – 8, 2019. The two posters highlighted how the Company’s Personal KinetiGraph®(PKG®) technology provided clinically meaningful improvements in Parkinson’s disease (PD) symptom assessment, management and medication optimization, and also enhanced patient-clinician conversations. 

Read the full press release here

Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors

 

Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first FDA-cleared and CE-marked wearable watch for the objective treatment and management of Parkinson’s disease, called the Personal KinetiGraph® (PKG®), today announced the appointment of Gregory Barrett, a distinguished medical device industry expert, as an independent director to its Board of Directors. 

 

Please read full press release here

Data Published in the Journal of Parkinson’s Disease Demonstrate Real-World Clinical Benefit of Global Kinetics’ Personal KinetiGraph® in Optimizing Parkinson’s Disease Therapy

Global Kinetics Corporation Ltd., in conjunction with the Parkinson’s Institute and Clinical Center, today announced the publication of a joint study in the Journal of Parkinson’s Disease. Study authors concluded that the Personal KinetiGraph® (PKG®), a wearable device that precisely monitors, quantifies, and reports movement symptoms in patients with Parkinson’s disease (PD), provided additional information beyond that which is typically captured during routine clinical visits.

 

Read full press release here